Obalon Therapeutics Inc. (OBLN)
NASDAQ: OBLN
· Real-Time Price · USD
3.05
-0.19 (-5.86%)
At close: Jun 16, 2021, 6:00 AM
Obalon Therapeutics Revenue
Obalon Therapeutics reported an annual revenue of $1.59M, reflecting a -51.6% growth. For the quarter ending June 30, 2021, Obalon Therapeutics generated $3.53K in revenue.
Revenue (ttm)
$1.59M
Revenue Growth
-51.6%
Price / Sales Ratio
7.34
Revenue / Employee
$794K
Employees
2
Market Cap
5.47M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|